Novo Nordisk, Europe’s largest company by market value, faced a stock market bloodbath on Friday after disappointing results ...
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.
5don MSN
A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, ...
Shares in Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, plunged ...
Shares in Ozempic maker Novo Nordisk crashed, after an experimental anti-obesity shot fell short of expectations. The shares ...
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
Denmark's drug regulator asks EMA to investigate potential link between Novo Nordisk's diabetes drug Ozempic and rare eye ...
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...
According to its website, Novo Nordisk was founded in 1923 in Copenhagen, Denmark’s capital city. It is best known for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback